Hafiz Muhammad Haris

4PUBLICATIONS
6CO-AUTHORS
Medical devicesMolecular targetsMedical infection agents (incl. prions)Quantum computation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 12, 2026
Taletrectinib as an emerging therapy for ROS1-positive non-small cell lung cancer: findings from TRUST phase 2 trials.

Hassan Khalid, Hafiz Muhammad Haris, Suleman Arshad

|Jul 06, 2025
Connecting the dots: How functional bladder capacity may reflect cardiovascular risk.

Momina Ahmed, Hafiz Muhammad Haris, Hafsa Zareen

Pageof 1